Table 4.

Rate of selected comorbidities (per 1000 yrs of followup) among 95 women and 91 men with AAV compared with 380 and 364 age- and index year–matched reference persons from background population.

ComorbiditiesRate CasesRate Reference PopulationRate Ratio95% CIp
IHD*
  Men40.025.51.60.9–2.70.1
  Women23.515.71.50.7–2.80.2
CVA*
  Men12.215.20.80.3–1.90.5
  Women14.29.51.50.6–3.50.3
HTN
  Men117.479.51.51.0–2.10.05
  Women84.765.91.30.9–1.80.2
DM
  Men41.527.01.50.8–2.70.1
  Women46.617.92.61.5–4.40.004
Dyslipoproteinemias
  Men8.124.80.30.1–0.90.002
  Women14.014.11.00.4–2.20.9
VTE*
  Men17.15.13.41.2–9.20.05
  Women14.32.75.31.7–19.50.02
Thyroid disease
  Men8.14.71.70.4–6.20.4
  Women48.321.62.21.3–3.70.01
Psychological disorders
  Men52.547.71.10.7–1.80.6
  Women70.970.61.00.7–1.50.9
Osteoporosis
  Men30.63.49.03.5–26.70.001
  Women63.416.83.82.3–6.2< 0.001
Fractures
  Men14.316.90.80.3–1.90.6
  Women27.122.41.20.6–2.20.5
  • * Only diagnoses assigned after hospitalization. AAV: antineutrophil cytoplasmic antibody–associated vasculitis; IHD: ischemic heart diseases; CVA: cerebrovascular accidents; HTN: hypertension; DM: diabetes mellitus; VTE: venous thromboembolism.